BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28669898)

  • 1. Relevance of tissue specific subunit expression in channelopathies.
    Seitter H; Koschak A
    Neuropharmacology; 2018 Apr; 132():58-70. PubMed ID: 28669898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics update: Monogenetics, polygene disorders and the quest for modifying genes.
    Symonds JD; Zuberi SM
    Neuropharmacology; 2018 Apr; 132():3-19. PubMed ID: 29037745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic principles underlying ion channelopathies.
    Cannon SC
    Neurotherapeutics; 2007 Apr; 4(2):174-83. PubMed ID: 17395127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the Flow of Excitation: TRP, Voltage-Gated Na(+), and Voltage-Gated Ca(2+) Channels in Contemporary Medicine.
    Frolov RV; Weckström M
    Adv Protein Chem Struct Biol; 2016; 103():25-95. PubMed ID: 26920687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion Transporters, Channelopathies, and Glucose Disorders.
    Demirbilek H; Galcheva S; Vuralli D; Al-Khawaga S; Hussain K
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-gated sodium channels: mutations, channelopathies and targets.
    Andavan GS; Lemmens-Gruber R
    Curr Med Chem; 2011; 18(3):377-97. PubMed ID: 21143119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-type Ca2+ channels in Ca2+ channelopathies.
    Striessnig J; Hoda JC; Koschak A; Zaghetto F; Müllner C; Sinnegger-Brauns MJ; Wild C; Watschinger K; Trockenbacher A; Pelster G
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1341-6. PubMed ID: 15336981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathies.
    Kline CF; Mohler PJ
    Biochim Biophys Acta; 2014 Feb; 1838(2):723-30. PubMed ID: 23732236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.
    Hull JM; Isom LL
    Neuropharmacology; 2018 Apr; 132():43-57. PubMed ID: 28927993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of membrane channels or channelopathies.
    Celesia GG
    Clin Neurophysiol; 2001 Jan; 112(1):2-18. PubMed ID: 11137655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited ion channel disorders.
    Surtees R
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S199-203. PubMed ID: 11216900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies.
    Sun J; Luo S; Song J; Huang J; Cai S; Zhu W; Zhou L; Xi J; Lin J; Lu J; Xu M; Dou T; Zhao C; Qiao K
    J Clin Neurophysiol; 2020 May; 37(3):231-238. PubMed ID: 31567646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion channel pharmacology.
    Camerino DC; Tricarico D; Desaphy JF
    Neurotherapeutics; 2007 Apr; 4(2):184-98. PubMed ID: 17395128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and new treatment in muscle channelopathies.
    Meola G; Hanna MG; Fontaine B
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):360-5. PubMed ID: 19289476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches to ion channel diseases.
    Camerino DC; Desaphy JF; Tricarico D; Pierno S; Liantonio A
    Adv Genet; 2008; 64():81-145. PubMed ID: 19161833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy and editing: Novel potential treatments for neuronal channelopathies.
    Wykes RC; Lignani G
    Neuropharmacology; 2018 Apr; 132():108-117. PubMed ID: 28564577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac voltage-gated calcium channel macromolecular complexes.
    Rougier JS; Abriel H
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1806-12. PubMed ID: 26707467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-gated calcium channels in genetic diseases.
    Bidaud I; Mezghrani A; Swayne LA; Monteil A; Lory P
    Biochim Biophys Acta; 2006 Nov; 1763(11):1169-74. PubMed ID: 17034879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Current and Prospective Treatments for Channelopathies, with a Focus on Gene and Protein Therapy.
    Sakla M; Breitinger U; Breitinger HG; Mansour S; Nabil Tammam S
    Curr Pharm Des; 2023; 29(17):1341-1360. PubMed ID: 37264658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channelopathies as a genetic cause of epilepsy.
    Mulley JC; Scheffer IE; Petrou S; Berkovic SF
    Curr Opin Neurol; 2003 Apr; 16(2):171-6. PubMed ID: 12644745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.